We propose the best approach for the diagnosis of fibrolamellar carcinoma is based on compatible morphology with either molecular confirmation, or if not available, then confirmation by CK7 and CD68 immunohistochemistry. Here, KRT7 is linked to fibrolamellar hepatocellular carcinoma.